 |
GEL-X™
POLLAK
has developed a prophylactic lubricating gel known as
Gel-X™ which serves as a solution for
both male and female, each of them independently, in the prevention of
transmission of Sexual Transmitted Diseases (S.T.D’s). Its main purpose
is to destroy HIV; Herpes Simplex Virus; Cytomegalovirus; Hepatitis B,
and other bacteria that might be transferred during intercourse. The
product is an antiseptic lubricating gel, for use as a sexual lubricant,
whilst simultaneously preventing the transmission of S.T.D's. The Company
has applied for and possesses patent protection for the product and its
applications.
Laboratory experiments (In Vitro) have proven that the active antiseptic
in Gel-X™ destroys the outer surface
of the virus, thus preventing its penetration into the cell. Due to its
excellent lubricating qualities, Gel-X™
reduces the tendency of tearing blood vessels during intercourse. The
interposition of the gel between both sexual members, and the fact that
it is present in the body fluids during intercourse, prevents the
transference of the virus to body tissues.
As a lubricant, Gel-X™ eases
penetration during intercourse. It is water soluble, and will only
dissolve completely when washed away with water, and is therefore
present throughout the entire sexual act.
Gel-X™ is not a medicine, and does not destroy HIV already
present in the body cells. The product provides options for both Male
and Female. The male applies Gel-X™
either by insertion of the erect organ into the sachet of
Gel-X™ or by manual application of the
gel onto the organ. For the female, Gel-X™
is inserted into the vagina by using an applicator.
Gel-X™ is the only existing microbicide
gel which can be controlled independently by the female.
Gel-X™ is not meant as a replacement
for the condom, but rather as an additional precautionary measure,
especially in high-risk situations, where additional safety precautions
are indicated. In cases where condoms are not used,
Gel-X™ serves a definite purpose.
Gel-X™ has been clinically tested In Vivo under the direction
and supervision of two highly reputed professors in the fields of
Gynecology, Obstetrics and Immunology in one of Israel's first class
hospitals and consequently recommended by them for use. Later, it was
also confirmed and recommended for use by an independent committee of
medical experts attached to Israel's largest medical Fund. In November
1993, Company representatives were invited to an Emergency Closed
Meeting on "Vaginal Microbicides for the Prevention of Heterosexual
Transmission of HIV," convened by the World Health Organization (WHO) in
Geneva. Gel-X™ complies with the
recommendations and specifications laid out by the WHO at this
convention.
Back to Research and
Development
|
